Written by Ad OpsComatose Strain Overview
Comatose, often marketed as Comatose OG in Canada, is a heavy, sedative indica known for dense resin production and night-time utility. It has become a staple in dispensaries that prize old-school Kush profiles, with consumers reporting powerful body relaxation and a swift easing of mental chatter. In typical lab tests from licensed producers, total THC frequently lands between 20% and 27%, while CBD stays below 1%, positioning Comatose among the stronger indica-dominant options.
Indica strains, broadly associated with relaxation, are consistently popular among consumers seeking calm and sleep support. Leafly’s 2025 overview of top indica strains underscores the continued demand for deeply relaxing varieties, and Comatose fits neatly into that trend as a couch-lock specialist. While individual experiences vary, the strain’s reputation for heaviness is well earned, especially when harvested at peak maturity.
The sensory signature of Comatose combines sharp citrus, pine, and earthy Kush with diesel undertones. The flavor follows suit—think lemon rind, damp forest, and a peppery finish—driven by a myrcene-caryophyllene-limonene terpene axis. For many, the last hour of the experience is a tranquil coast to sleep, making it a preferred choice for late evenings and recovery days.
Origin and History
Comatose has deep roots in the Canadian craft scene, particularly in British Columbia’s long-respected legacy market. In the 2000s and early 2010s, BC breeders circulated several Kush-leaning cuts that favored dense buds, heavy resin, and sedative effects. Comatose emerged from that environment as a clone-forward cultivar that excelled in cool, coastal climates and indoor rooms alike.
While precise origin stories can be foggy in legacy-to-legal transitions, most accounts connect Comatose to OG Kush heritage. Growers emphasize its stability when dialed in—thick stalks, manageable internodes, and a flowering time that rarely exceeds nine weeks. These traits helped it cross over into legal shelves where consistent harvest timing matters for production planning.
As the legal market matured, Comatose maintained relevance due to its reliable effects and terpene profile aligned with evening use. Consumers seeking a modern alternative to classics like Bubba Kush often land on Comatose for a similar but zestier citrus-pine nose. The combination of potency, aroma clarity, and grower familiarity positioned it as a durable entry in the indica category.
Genetic Lineage and Breeding Notes
Comatose is generally described as an indica-dominant Kush descendant, commonly linked to OG Kush ancestry. Some breeder notes suggest a selection from an OG Kush lineage crossed or backcrossed to reinforce sedative traits, though exact parentage is not universally documented. This lack of a single codified pedigree is common for legacy strains that garnered fame through consistent effects rather than branded breeding lines.
Phenotypically, Comatose leans indica in structure with compact nodes and broad leaves, but it may express modest stretch during early flowering. The strain typically shows a 1.5x stretch under high-intensity LED lighting, allowing it to fit neatly into Scrog or low-profile vertical racks. Bud formation favors tight calyx stacking, which boosts bag appeal but requires careful humidity control nearing harvest.
Breeders who use Comatose in crosses typically aim to capture its sedative body load and resin thickness while lightening the density to resist botrytis. Outcrossing to more open-structured hybrids can improve airflow in humid grows. Conversely, keeping Comatose close to Kush genetics preserves the lemon-pine-earth flavor set that many consumers consider essential.
Appearance and Bud Structure
Comatose buds are dense, golf-ball to egg-shaped, and heavily encrusted with trichomes. The coloration trends olive green with darker sugar leaves and vibrant orange pistils that thread across the surface. Under magnification, trichome heads are plentiful and bulbous, often milky with a healthy proportion turning amber when harvested later for a more soporific effect.
The calyxes stack tightly with minimal foxtailing when temperatures are managed below 28 Celsius during late flower. Sugar leaves often curl slightly inward around the buds, emphasizing the compact, weighty structure. With proper curing, the buds break apart with a snap rather than crumble, indicating good moisture levels and terpene retention.
Growers should note that the same density that benefits visual appeal increases the risk of mold if airflow is neglected. De-leafing and strategic canopy spacing help reveal the bud faces to moving air. This is especially critical in the final two weeks when surface moisture on densely packed flowers is most risky.
Aroma and Flavor
The aroma opens with bright lemon-lime and orange peel notes, quickly shaded by wet forest, pine needles, and a Kushy base. As the jar breathes, earthy diesel and a faint herbal spice emerge, suggesting a cooperation between myrcene, beta-caryophyllene, and limonene. Many users describe the smell as zesty but grounded—clean citrus meeting classic Kush musk.
On the palate, Comatose delivers citrus-pine upfront with a peppery, woody finish. The lemon character lingers on the tongue, while the exhale vents herbal-diesel nuances reminiscent of OG Kush. A slow, cool draw preserves the lighter top notes that can be lost at high temperatures.
Vaporizing at 175–190 Celsius tends to emphasize the citrus and pine while tempering the diesel bite. Combustion at higher heat skews toward pepper and earth, underlining the caryophyllene content. Whichever method is chosen, a proper cure dramatically improves the clarity and separation of these flavors.
Cannabinoid Profile
Licensed lab results for Comatose commonly report THC in the 20–27% range, with occasional batches slightly outside that depending on phenotype and cultivation. CBD is typically low, often below 0.5%, and rarely exceeding 1%. Minor cannabinoids like CBG usually appear in the 0.2–1.0% window, while THCV and CBC present in trace amounts.
For inhalation, the rapid onset and high THC align with strong subjective sedation, especially for users with lower tolerance. Edible infusions of Comatose can deliver a longer, heavier arc due to hepatic metabolism of THC into 11-hydroxy-THC, which is more potent per milligram. Consumers sensitive to strong THC should begin with small doses to avoid over-sedation.
The total active cannabinoid content often reaches 22–29% when including minors, contributing to the overall potency. Differences in drying, curing, and post-harvest storage can shift these numbers by several percentage points. Lab-tested product with harvest date and potency window on the label is the most reliable way to gauge dose strength.
Terpene Profile
Comatose typically expresses a terpene total between 1.5% and 3.0% by weight when grown and cured optimally. Myrcene is commonly dominant, often in the 0.6–1.2% range, followed by beta-caryophyllene at 0.3–0.7%. Limonene frequently appears at 0.2–0.5%, with supporting roles from humulene 0.1–0.2%, linalool 0.1–0.3%, and pinene 0.05–0.15%.
This profile aligns with the sensory and experiential character of the strain—myrcene contributing to the musky-earth base and body heaviness, caryophyllene adding pepper and potential anti-inflammatory properties, and limonene brightening the citrus top notes. Linalool, where present, can add a faint floral-soap thread and may deepen the calming tone. Humulene and pinene round out the woodland and resinous impressions that echo classic Kush lines.
Research and product guides often highlight these terpenes for their potential roles in pain and stress modulation. For example, coverage of strains like Runtz has emphasized the anti-inflammatory and analgesic potential of beta-caryophyllene, linalool, and limonene—a trio that also commonly appears in Comatose. While terrestrial percentages vary by grow, the recurring pattern supports the perception of Comatose as a high-relaxation cultivar.
Experiential Effects
The inhaled onset is usually felt within 5–15 minutes, starting as a warm body drift and softening behind the eyes. As the peak settles at 30–60 minutes, muscle heaviness and couch-lock are common, accompanied by a quieting of internal dialogue. Many users report that mental stress detaches rather than disappears, replaced by a slow, tranquil focus on simple comforts.
The duration of inhaled effects commonly spans 2–4 hours depending on dose and tolerance, with the final hour tipping toward sleepiness. For edibles, the total experiential window can extend to 6–8 hours with a prolonged, heavy tail. Most consumers therefore reserve Comatose for late evenings, movie nights, and pre-sleep rituals.
Functionally, Comatose tends to dull background discomfort and promote stillness. Creative or social energy is generally lower than with hybrid or sativa-leaning strains, aligning it with recovery days rather than task-heavy schedules. Hydration and a light snack help some users manage the deep relaxation without feeling overly immobilized.
Potential Medical Uses
Patients and adult consumers commonly reach for Comatose for sleep initiation and maintenance, especially when insomnia is tied to ruminating thoughts. Observational reports suggest sedative indicas can improve sleep onset latency and continuity, which lines up with Comatose’s heavy tail. Using small to moderate inhaled doses 60–90 minutes before bed is a pattern many find effective.
Pain management is another frequent use case, particularly for musculoskeletal and neuropathic discomfort that flares at day’s end. Though not a substitute for clinical care, Comatose’s myrcene-caryophyllene-limonene profile tracks with terpenes discussed for analgesia and anti-inflammatory support. Many users report a subjective 20–40% reduction in pain intensity during the peak window, depending on dose and tolerance.
Fatigue, depression, and anxiety are often intertwined in chronic conditions like fibromyalgia. Leafly’s guidance on fibromyalgia notes that there are many strains that can address pain, fight fatigue, reduce depression and anxiety, sharpen focus, and crush insomnia. In this spectrum, Comatose is best positioned for the pain and insomnia end of the range rather than the focus-boosting side, making it a potential night-time tool in a broader symptom management plan.
Consumers should discuss cannabis use with a clinician, especially if taking sedatives, antidepressants, or antiepileptics. Individuals with a history of cannabis sensitivity or panic reactions may prefer lower-THC, balanced CBD-THC options. Start low and monitor response over several sessions to establish a consistent, helpful dose.
Dosing, Onset, and Side Effects
For inhalation, beginners should consider 1–2 inhalations and wait 10–15 minutes before deciding on more. Experienced consumers often find 5–10 mg THC per session sufficient with a strain like Comatose, while sensitive users may prefer half that. Edible users should start with 2.5–5 mg THC and allow 2 hours before re-dosing to avoid stacking effects.
Side effects include dry mouth, dry eyes, orthostatic lightheadedness, and increased appetite. In higher doses, some users report residual grogginess the next morning, especially with late-night consumption. Lowering the dose or advancing the dosing time earlier in the evening often helps mitigate these effects.
Allergic reactions to cannabis are documented in the literature and consumer press. Leafly’s overview of cannabis allergies notes that marijuana allergies are real and can present as rhinitis, skin irritation, or in rare cases more serious symptoms. Individuals with known plant allergies should handle flower with gloves, avoid rubbing eyes, and consider vaporizing to minimize exposure to airborne particulates.
Cultivation Guide - Growth Habits and Setup
Comatose is a photoperiod indica-dominant plant with a compact to medium stature. Indoors, plants commonly finish at 0.8–1.2 meters with a moderate 1.4–1.6x stretch in the first three weeks of 12-12. This makes Comatose suitable for tents, short rooms, and multi-tier vertical racks when properly topped and trained.
Flowering time is typically 8–9 weeks from the flip, with some phenotypes ripening at day 56 and others preferring 63–65 days for full resin maturity. The cultivar’s tight bud structure rewards consistent environmental control, especially during weeks 6–9. Expect above-average trichome density that can make plants sticky to the touch by week 5.
Yields vary with method, but 400–550 g per square meter is attainable indoors using a SCROG or SOG in dialed rooms. Outdoors, plants can produce 500–900 g per plant in temperate climates with good sun and diligent pruning. Harvest windows in the Northern Hemisphere generally fall from late September to early October, depending on latitude and phenotype.
Cultivation Guide - Environment, Medium, and Nutrition
Comatose thrives in a stable, moderately warm environment. Target daytime temperatures of 24–28 Celsius and nighttime of 18–22 Celsius. Maintain relative humidity at 60–70% in vegetative growth, 45–55% in early flower, and 40–45% in late flower to reduce botrytis risk.
For lighting, aim for 300–500 µmol m−2 s−1 PPFD in veg and 700–900 µmol m−2 s−1 in flower, equating to daily light integrals near 25–35 mol m−2 day−1 in veg and 35–50 in flower. CO2 enrichment to 900–1,200 ppm can increase flower density and terpene output if temperature, nutrition, and watering are tuned to match. Keep air movement steady with oscillating fans to eliminate microclimates around dense colas.
In coco or hydro, maintain pH at 5.8–6.2 and electrical conductivity around 1.2–1.8 mS cm−1 in veg, stepping to 1.8–2.2 mS cm−1 in peak flower. In soil, a pH of 6.2–6.8 is a solid target, with organic top-dressing and microbial inoculants supporting terpene richness. Comatose responds well to a mild nitrogen taper starting week 4 of flower and a potassium-phosphorus emphasis from weeks 5–7.
Watering frequency should match pot volume and medium; allow for a healthy wet-dry cycle without complete dryness that can stress roots. In living soil, mulch helps retain moisture and support beneficial fungi. In inert media, ensure runoff of 10–20% per feed to prevent salt buildup, especially critical late in bloom.
Cultivation Guide - Training, Flowering, and Yield Optimization
Top or FIM once or twice in veg to establish 6–12 main sites, then use low-stress training or a trellis to build a flat canopy. Comatose’s internodal structure makes it ideal for SCROG, which evenly exposes dense buds to light and airflow. Defoliate lightly in week 3 of flower to remove large fan leaves that shade interior shoots.
Expect a 1.5x stretch, so set the trellis before flip and guide branches into even squares. Prune lower growth that will not receive strong light to focus energy on the top 12–18 inches of the canopy. This cultivar rewards uniform canopies with improved bud size consistency and lower risk of mold.
Flush strategies vary by cultivation style, but many growers reduce EC by 20–30% in the final 10–14 days to clean up the finish. Monitor runoff EC and leaf color rather than following a rigid schedule. A gentle taper preserves terpene complexity while avoiding a harsh, nutrient-laden burn.
Cultivation Guide - IPM, Pests, and Disease Prevention
Dense indica flowers invite powdery mildew and botrytis if humidity and airflow drift out of range. Maintain late-flower VPD near 1.2–1.5 kPa and avoid temperature dips that condense moisture on colas. Space plants adequately and use box fans or under-canopy air movers to keep microclimates from forming around bud clusters.
Integrated pest management should start in veg with preventative biologicals and sanitation. Sticky cards, regular leaf inspections, and quarantine of inco
